NCT01772381

Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus

Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 600 (actual)
• Sponsor: Ain Shams Maternity Hospital · Academic / Other
• Sex: Female
• Age: 22 Years – 44 Years
• Healthy volunteers: Accepted

Summary

Introduction: Babies born at term by elective caesarean section (CS) and before onset of labor are more likely to develop respiratory complications than babies born vaginally. In developing countries resources are scarce and it is difficult to provide expensive treatments as neonatal care. Aim of the Work: To assess the effect of prophylactic dexamethasone administration before elective cesarean section at term in reducing neonatal respiratory complications. Patients and methods: 600 women were included in the study and were planned to have elective caesarean section. 300 received dexamethasone 12 mg twice, 12 hours apart 48 hours before delivery. 300 patients were the control group. The outcomes were: incidence of admission to neonatal intensive care unit (NICU), incidence of transient tachypnea of newborn (TTN), the incidence of respiratory distress syndrome (RDS) and the need for mechanical ventilation.

Detailed description

Dexamethasone which is a long acting corticosteroid can be used prior to elective cesarean section to decrease neonatal respiratory morbidity by enhacing fetal lung maturity.

Conditions

• Transient Tachypnea of the Newborn

Interventions

Type	Name	Description
DRUG	Dexamethasone	Long acting corticosteroid

Timeline

• Start date: 2010-03-01
• Primary completion: 2011-03-01
• Completion: 2011-06-01
• First posted: 2013-01-21
• Last updated: 2013-01-21

Locations

1 site across 1 country: Egypt